Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference for Monthly Ibandronate vs Weekly Alendronate in Postmenopausal Osteoporosis
NCT02598440Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibandronate in postmenopausal osteoporosis, sponsored by Roche. Started Mar 2004; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT02598440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598440.